Cimiside E exhibits anti-inflammatory activity by selectively inhibiting TNF-alpha-induced VCAM-1 expression, an effect mediated through PPAR-gamma upregulation and involving ERK1/2, PI3K, and PKC signaling. It also demonstrates potential chemopreventive properties against gastric cancer by inducing cell cycle arrest and apoptosis in vitro.
Molekulargewicht:
602.809
CAS Nummer:
[154822-57-8]
Formel:
C35H54O8
Target-Kategorie:
Caspase,PKC,Akt,PI3K,TNF,ROS,ERK,PPAR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten